Zetterberg and Blennow, 2021
Featured in AD Review Series: Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Henrik Zetterberg and Kaj Blennow
Moore et al. 2021
Featured in AD Review Series: Remodeling Alzheimer-amyloidosis models by seeding
Brittany S. Ulm, David R. Borchelt & Brenda D. Moore
Zerr et al. 2021
Featured Research: Prion protein oligomers cause neuronal cytoskeletal damage in rapidly progressive Alzheimer’s disease
Mohsin Shafiq, Saima Zafar, …, and Inga Zerr
Zheng et al. 2021
Featured Research: Clusterin secreted from astrocyte promotes excitatory synaptic transmission and ameliorates Alzheimer’s disease neuropathology
Fading Chen, …, Baiping Wang and Hui Zheng
Fryer et al. 2021
Featured Research: Astrocyte-derived clusterin suppresses amyloid formation in vivo
Aleksandra M. Wojtas, …, Chia-Chen Liu and John D. Fryer
Wellington et al., 2020
Featured Research: An in vitro bioengineered model of the human arterial neurovascular unit to study neurodegenerative diseases
Jerome Robert, …, Cheryl L. Wellington
Articles
-
-
AIF3 splicing switch triggers neurodegeneration
-
Adiponectin-mimetic novel nonapeptide rescues aberrant neuronal metabolic-associated memory deficits in Alzheimer’s disease
-
TREM2/PLCγ2 signalling in immune cells: function, structural insight, and potential therapeutic modulation
-
Fred W. van Leeuwen (1949–2021)
Editor highlights
Alzheimer's Disease: Challenges for the next decade
Molecular Neurodegeneration presents a new thematic series, collating reviews which present and evaluate the challenges for the next decade of research into Alzheimer's disease.
Edited by Guojun Bu, Alison Goate and Todd Golde, reviews will continue to publish throughout 2021. The collection can be read here.
News from Alzforum
-
In Pilot Study, Electric Therapy Improves Memory
17 April 2021
-
-
Tau, Speckle Wrecker, Disrupts the Nuclear Home
16 April 2021
About Us
The leading open access journal in the field of neurosciences, Molecular Neurodegeneration encompasses all aspects of neurodegeneration research at the molecular and cellular levels.
Follow
Annual Journal Metrics
-
Speed
58 days to first decision for reviewed manuscripts only
32 days to first decision for all manuscripts
153 days from submission to acceptance
28 days from acceptance to publication
Citation Impact
9.599 - 2-year Impact Factor
8.595 - 5-year Impact Factor
1.671 - Source Normalized Impact per Paper (SNIP)
4.040 - SCImago Journal Rank (SJR)
Usage
770,533 downloads
723 Altmetric mentions
